BioPharmSignal logoBioPharmSignal

Biotech News

MATERIALISE SHARE-BUY BACK PROGRAM

Materialise (MTLS)MaterialiseCompany update

Leuven – 20 July 2026 – 22h00 CET Regulated information[1] Materialise reports on the progress of its share buy-back program announced on 30 October 2025. 20 July 2026 – Materialise NV (Euronext: MTLS) (Nasdaq: MTLS) (“Materialise”) (“the Company”) hereby discloses certain information in relation

Related news

MTLSMaterialise2026-07-20 20:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

MTLSMaterialise2026-07-01 20:05 EST

Annual General Meeting of Materialise NV held at the registered office of the Company on Tuesday 16 June 2026 at 10:00 (CET): Resolutions

View all latest news

Materialise

Additive-Manufacturing Technology Materialise is a global 3D-printing company providing software, production services and medical applications. Its technology supports the design and manufacture of complex parts from digital models. Medical Solutions The medical segment develops patient-specific surgical planning tools, anatomical...

Recent company news

MTLSMaterialise2026-07-20 20:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

MTLSMaterialise2026-07-20 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

MTLSMaterialise2026-07-13 20:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

MTLSMaterialise2026-07-13 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

MTLSMaterialise2026-07-06 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

Stock data

Close
6.75 USD
Market cap
401.4M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States